PUBLIC CONTRACT · 2026
Aquisição de vinORELBina, Nivolumab e Pemetrexedo - CPA 491/2023
- Contract value
- €105,701.30
- Signed on
- 18 September 2026
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 15787933PUBLISHED DESCRIPTION
Aquisição de vinORELBina 10mg/ml 5 ML IV, Nivolumab 10 mg/ml Sol inj Fr 4 ml IV e 10mL IV, PemeTREXEDO 25 mg/ml Sol inj Fr 40 ml IV e 20 ml - CPA 491/2023
Parties involved
- Place of performance
- Portugal, Viana do Castelo, Viana do Castelo
- NUTS region
- PT111 - Alto Minho
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- BRISTOL - MYERS SQUIBB Farmacêutica Portuguesa, SA · Tax ID 500048193
Values and timeline
- Contract price
- €105,701.30
- Procedure base price
- €235,393.30
- Total effective price
- Not reported on Portal BASE
- Publication date
- 16 October 2026
- Award date
- 17 September 2026
- Signing date
- 18 September 2026
- Performance period
- 0 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- 491/2023 - Concurso público internacional para formação do acordo quadro de medicamentos do foro oncológico e imunomoduladores
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 11511362
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.